Alexander Hardy
Chief Executive Officer at BioMarin Pharmaceutical Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: BioMarin Pharmaceutical Inc., 2 years.
BioMarin Pharmaceutical Inc.
Director · Chief Executive Officer
Chief executive roles
BioMarin Pharmaceutical Inc.
· Chief Executive Officer
Since December 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −4,252 | $56.05 | $238,325 |
| Mar 16, 2026 | BioMarin Pharmaceutical Inc. | Grant or award | +62,440 | — | — |
| Mar 13, 2026 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −2,941 | $58.51 | $172,078 |
| Dec 1, 2025 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −16,570 | $55.03 | $911,847 |
| Apr 30, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +375 | $54.14 | $20,303 |
| Mar 17, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +44,360 | — | — |
| Mar 14, 2025 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −2,933 | $69.44 | $203,668 |
| Nov 29, 2024 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −14,295 | $66.03 | $943,899 |
| Oct 31, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +300 | $56.01 | $16,803 |
| Mar 15, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +32,780 | — | — |
| Dec 1, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +68,039 | — | — |
| Dec 1, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +47,332 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.